ArticleImmunity2026

Pharmacologic glycoengineering of Fcγ receptor IIIa enhances force-resistant IgG-FcγR interactions and anti-tumor antibody efficacy.

Bowie Yik-Ling Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.